Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin ; volume:13 ; number:5 ; day:27 ; month:10 ; year:2011 ; pages:1-14 ; date:10.2011
Breast cancer research ; 13, Heft 5 (27.10.2011), 1-14, 10.2011
- Creator
-
Mendoza-Villanueva, Daniel
- Contributor
-
Zeef, Leo
Shore, Paul
SpringerLink (Online service)
- DOI
-
10.1186/bcr3048
- URN
-
urn:nbn:de:1111-2016032412562
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mendoza-Villanueva, Daniel
- Zeef, Leo
- Shore, Paul
- SpringerLink (Online service)
Other Objects (12)
Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase
Titanium particles damage osteocytes and inhibit osteoblast differentiation
Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation
Retraction Note: Titanium particles damage osteocytes and inhibit osteoblast differentiation
METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3
B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation
Circulating Exosomes from Mice with LPS-Induced Bone Loss Inhibit Osteoblast Differentiation
Sclerostin and Cardiovascular Disease
Die Untersuchung des Transkriptionsfaktors RUNX2, insbesondere die RUNX2-Cbfβ-Interaktion [RUNX2-Cbf-Beta-Interaktion] in der Pathogenese der cleidocranialen Dysplasie
Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase
Titanium particles damage osteocytes and inhibit osteoblast differentiation
Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation
Retraction Note: Titanium particles damage osteocytes and inhibit osteoblast differentiation
METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3
B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation
Circulating Exosomes from Mice with LPS-Induced Bone Loss Inhibit Osteoblast Differentiation
Sclerostin and Cardiovascular Disease
Die Untersuchung des Transkriptionsfaktors RUNX2, insbesondere die RUNX2-Cbfβ-Interaktion [RUNX2-Cbf-Beta-Interaktion] in der Pathogenese der cleidocranialen Dysplasie
Epigenetic regulation of Runx2 transcription and osteoblast differentiation by nicotinamide phosphoribosyltransferase
Titanium particles damage osteocytes and inhibit osteoblast differentiation
Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation
Retraction Note: Titanium particles damage osteocytes and inhibit osteoblast differentiation
METTL3-mediated m6A modification increases Hspa1a stability to inhibit osteoblast aging
RUNX2 promotes the suppression of osteoblast function and enhancement of osteoclast activity by multiple myeloma cells
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
Runx2 is required for the proliferation of osteoblast progenitors and induces proliferation by regulating Fgfr2 and Fgfr3
B cells inhibit bone formation in rheumatoid arthritis by suppressing osteoblast differentiation
Circulating Exosomes from Mice with LPS-Induced Bone Loss Inhibit Osteoblast Differentiation
Sclerostin and Cardiovascular Disease